1. Home
  2. YORW vs AUTL Comparison

YORW vs AUTL Comparison

Compare YORW & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo York Water Company (The)

YORW

York Water Company (The)

N/A

Current Price

$32.95

Market Cap

552.3M

Sector

Utilities

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

N/A

Current Price

$1.90

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YORW
AUTL
Founded
1816
2014
Country
United States
United Kingdom
Employees
104
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.3M
596.2M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
YORW
AUTL
Price
$32.95
$1.90
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$34.00
$8.50
AVG Volume (30 Days)
93.3K
2.2M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
3.13%
N/A
EPS Growth
N/A
N/A
EPS
0.82
N/A
Revenue
$77,488,000.00
$10,120,000.00
Revenue This Year
$11.78
$80.32
Revenue Next Year
$4.95
$53.96
P/E Ratio
$40.45
N/A
Revenue Growth
3.37
496.00
52 Week Low
$28.26
$1.18
52 Week High
$34.81
$2.58

Technical Indicators

Market Signals
Indicator
YORW
AUTL
Relative Strength Index (RSI) 46.72 41.61
Support Level $29.37 $1.37
Resistance Level $34.06 $2.07
Average True Range (ATR) 0.46 0.10
MACD -0.23 -0.08
Stochastic Oscillator 4.73 15.00

Price Performance

Historical Comparison
YORW
AUTL

About YORW York Water Company (The)

The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: